Absence of association between Alzheimer disease and the regulatory region polymorphism of the PS2 gene in an Italian population

Neuroscience Letters

Volumn 343, Issue 3, 2003, Pages 210-212

  Di Natale, Manuela ^a   Perri, Maria ^a   Kawarai, Toshitaka ^b,c   Maletta, Raffaele ^a   Tomaino, Carmine ^a   Sato, Christine ^b,c   Nacmias, Benedetta ^d   Shibata, Nobuto ^b,c   Sorbi, Sandro ^d   St George Hyslop, Peter H ^b,c   Bruni, Amalia C ^a   Rogaeva, Ekaterina ^b,c  

^a Ctro Regionale Neurogenetica AS 6   (Italy)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer disease; Polymorphism; Presenilin 2; Promoter; Susceptibility factor

Indexed keywords

PRESENILIN 2; APOLIPOPROTEIN E; MEMBRANE PROTEIN; PSEN2 PROTEIN, HUMAN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ETHNOLOGY; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; ITALY; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; ITALY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PRESENILIN-2; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 12144286265     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00335-5     Document Type: Article

References (13)

1. Farrer L.A., Bowirrat A., Friedland R.P., Waraska K., Korczyn A.D., Baldwin C.T. Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum. Mol. Genet. 12:(4):2003;415-422.
2. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. J. Am. Med. Assoc. 278:1997;1349-1356.
3. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Rebecca M., Newron P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
4. McKhann G., Drachman G., Folstein M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
5. Pericak-Vance M.A., Bebout J.L., Gaskell P.C. Jr., Yamaoka L.H., Hung W.Y., Alberts M.J., Walker A.P., Bartlett R.J., Haynes C.A., Welsh K.A. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48:1991;1034-1050.
6. Riazanskaia N., Lukiw W., Grigorenco A., Korovaitseva G., Dvoryanchikov G., Moliaka Y., Nicolaou M., Farrer L., Bazan N.G., Rogaev E. Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD. Mol. Psychiatry. 7:(8):2002;891-898.
7. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
8. Rogaeva E. The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease. J. Neuromol. Med. 2:(1):2002;1-10.
9. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
10. Sherrington R., Froelich S., Sorbi S., Campion D., Chi H., Rogaeva E.A., Levesque G., Rogaev E.I., Lin C., Liang Y., Ikeda M., Mar L., Brice A., Agid Y., Percy M.E., Clerget-Darpoux F., Piacentini S., Marcon G., Nacmias B., Amaducci L., Frebourg T., Lannfelt L., Rommens J.M., George-Hyslop P.H. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum. Mol. Genet. 5:1996;985-988.
11. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
12. Theuns J., Del-Favero J., Dermaut B., van Duijn C.M., Backhovens H., Van den Broeck M.V., Serneels S., Corsmit E., Van Broeckhoven C.V., Cruts M. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. Hum. Mol. Genet. 9:2000;325-331.
13. Theuns J., Van Broeckhoven C. Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility. Hum. Mol. Genet. 9:2000;2383-2394.